Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-3 of 3
Keywords: PD-1
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Karolina Bednarska, Gayathri Thillaiyampalam, Sally Mujaj, Jamie Nourse, Jay Gunawardana, Muhammed B. Sabdia, Soi C. Law, Anna Pilaar, Qingyan Cui, Lilia M. de Long, Frank Vari, Maher K. Gandhi, Alexandre S. Cristino
Journal:
Acta Haematologica
Acta Haematol (2024) 147 (6): 676–691.
Published Online: 14 March 2024
... complex class I, rendering it susceptible to antitumoral immunity by natural killer (NK) cells. Despite the functional impairment of PD-1 + NK cells in HL, the underlying mechanisms of NK cell dysfunction remain unclear. Methods: This study involved 14 HL patients and SNK10/KHYG-1 cell lines to assess NK...
Journal Articles
Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents
Open Access
Journal:
Acta Haematologica
Acta Haematol (2024) 147 (1): 73–83.
Published Online: 04 September 2023
... to in the content or advertisements. 2023 Richter’s transformation Accelerated chronic lymphocytic leukemia Diffuse large B-cell lymphoma Novel agents Bruton tyrosine kinase inhibitor B-cell lymphoma-2 PD-1 Chimeric antigen receptor T cell There are currently three histological and clinical...
Journal Articles
Anti-PD-1-Targeted Therapies Focusing on Lymphatic Malignancies: Biological Rationale, Clinical Challenges and Opportunities
Available to Purchase
Journal:
Acta Haematologica
Acta Haematol (2015) 133 (2): 129–135.
Published Online: 16 February 2015
... in spite of maximal therapy. Both solid tumors and lymphoid malignancies develop mechanisms in order to escape destruction by the intact immune system. One such mechanism is mediated through immune checkpoints. PD-1 (programmed cell death protein-1, which is expressed on activated T and B cells, natural...